In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization

NCT ID: NCT07100626

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-24

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to answer are:

* Can BlueCheck® reliably detect early carious lesions with high sensitivity and specificity?
* Does BlueCheck® visually reflect changes in remineralized enamel lesions?

BlueCheck® results will be compared against standard diagnostic methods (e.g., Nyvad criteria, Diagnodent readings, surface microhardness) to see if BlueCheck® provides an objective, accurate, and visual method of detecting and monitoring early-stage caries.

Participants will:

* Wear a modified lower partial denture with four mounted enamel specimens for 28 days.
* Use only the study-provided fluoride containing toothpaste
* Attend weekly clinic visits for removal and laboratory analysis of one enamel specimen per week.
* Undergo regular oral health checks and provide diary entries tracking brushing and any adverse events.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BlueCheck

Caries Detection and Monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* provide voluntary, written informed consent;
* be between 18 and 85 years old;
* understand and be willing, able and likely to comply with all study procedures and restrictions;
* be wearing a removable mandibular partial denture with sufficient room to accommodate four (4) human enamel specimens (4 mm round) in their partial denture on both sides (two specimens on each side, bilateral partial denture) or one side (4 specimens on one side, unilateral partial denture)
* be willing and capable of wearing their removable partial denture 24 hours a day for four (4), one-week treatment periods, maximum total duration four (4) weeks;
* be willing to allow study personnel to drill specimen sites in the posterior section of one or both sides of their lower partial denture (teeth and/or buccal flange area below the teeth); and
* be in good medical and dental health with no active caries or periodontal disease.
* have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate ≥ 0.2 mL/min; gum base stimulated whole saliva flow rate ≥ 0.8 mL/min).

Exclusion Criteria

* currently be pregnant (self-reported), intending to become pregnant during the study period or breast feeding;
* currently have any medical condition that could be expected to interfere with the subject's safety during the study period;
* currently be taking antibiotics or have taken antibiotics in the two weeks prior to the beginning treatment;
* known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients;
* have participated in another clinical study or receipt of an investigational drug within 30 days of beginning treatment; or
* be taking fluoride supplements, required to use a fluoride mouthrinse or have received a professional fluoride treatment in the two weeks preceding specimen placement.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oral Health Research Institute, Indiana University School of Dentistry

UNKNOWN

Sponsor Role collaborator

Incisive Technologies Pty Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frank Lippert, PhD

Role: PRINCIPAL_INVESTIGATOR

Oral Health Research Institute, Indiana University School of Dentistry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oral Health Research Institute

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

25-I-126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.